Special Issues
Table of Content

Emerging Insights into the Tumor Microenvironment: Mechanisms, Therapeutic Targets, and Clinical Applications

Submission Deadline: 30 September 2025 (closed) View: 683 Submit to Journal

Guest Editor(s)

Prof. Yong Teng

Email: yong.teng@emory.edu

Affiliation: Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA

Homepage:

Research Interests: metastasis; molecular pathway; cancer models; metabolism; tumor microenvironment; drug screening and development


Prof. Nabil F Saba

Email: nfsaba@emory.edu

Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA

Homepage:

Research Interests: Head and Neck Cancer, Clinical and Translational Research; Immunotherapy, Novel Systemic therapy approaches

图片1.png


Summary

The tumor microenvironment (TME) plays a pivotal role in the initiation, progression, and therapeutic resistance of cancers. This dynamic ecosystem, comprising cancer cells, stromal cells, immune cells, and extracellular matrix components, creates a complex network of interactions that influence tumor behavior. Understanding the mechanisms underlying TME dynamics is essential for developing innovative therapeutic strategies and improving patient outcomes.  

 

This special issue aims to explore the latest advances in TME research, including its molecular and cellular components, role in immune evasion, and influence on therapeutic resistance. Submissions are invited on topics such as TME-targeted therapies, the development of predictive biomarkers, and innovative models for studying the TME. Both experimental and clinical studies, as well as comprehensive reviews, are welcome.  

 

We believe this special issue will provide a platform to advance our understanding of the TME and foster the development of novel interventions in cancer therapy. 


Keywords

Tumor Microenvironment (TME), Cancer Immunotherapy, Tumor-Immune Interactions, Extracellular Matrix Remodeling, Angiogenesis in Cancer, Therapeutic Resistance, Tumor-Associated Stromal Cells, Biomarkers in TME

Published Papers


  • Open Access

    ARTICLE

    Dysregulated Cell Signaling Pathways in Prostate Tumoral Plasticity—Checkpoints

    Elena Matei, Ionuț Ciprian Iorga, Mariana Deacu, Georgeta Camelia Cozaru, Gabriela Isabela Băltățescu, Manuela Enciu
    Oncology Research, Vol.34, No.6, 2026, DOI:10.32604/or.2026.072421
    (This article belongs to the Special Issue: Emerging Insights into the Tumor Microenvironment: Mechanisms, Therapeutic Targets, and Clinical Applications)
    Abstract Objectives: Deregulated plasticity is involved in initiation, progression, metastasis, and resistance to therapy of various cancers. Our study aimed to present new checkpoints involved in complex biological processes that sustain epithelial-mesenchymal transition (EMT) variability and heterogeneity in prostate tumor cell plasticity. Methods: Dysregulated cell signaling pathways involved in prostate EMT heterogeneity were analyzed by intrinsic and extrinsic factors such as cell cycle phases by propidium iodide (PI) stain, apoptosis by caspase-3/7 biochemical cascade DEVDase enzyme activity by Magic Red stain (DEVD-MR)/propidium iodide stain, autophagy and nuclear shrinkage by Hoechst/acridine orange stain, evasion of immune surveillance by… More >

  • Open Access

    ARTICLE

    HE4 Might Participate in Extracellular Matrix Remodeling in Ovarian Cancer via Activation of Fibroblasts

    Yimin Liu, Bin Liu, Huabin Gao, Jinlong Wang, Jingya Duan, Xiaolan Huang, Yuexi Liu, Ying Huang, Wenjing Liao, Ruonan Li, Hua Linghu
    Oncology Research, Vol.34, No.1, 2026, DOI:10.32604/or.2025.069007
    (This article belongs to the Special Issue: Emerging Insights into the Tumor Microenvironment: Mechanisms, Therapeutic Targets, and Clinical Applications)
    Abstract Objectives: High-grade serous ovarian cancer (HGSOC), the most common subtype of epithelial ovarian cancer (EOC), exhibits a mesenchymal phenotype characterized by fibrotic stroma and poor prognosis. Human epididymis protein 4 (HE4), a key diagnostic biomarker for ovarian cancer, is involved in fibrotic processes in several non-malignant diseases. Given the clinical significance of stromal fibrosis in HGSOC and the potential link between HE4 and fibrosis, this study aimed to investigate the role of HE4 in the formation of stromal fibrosis in HGSOC. Methods: A total of 126 patients with gynecological conditions were included and divided into… More >

    Graphic Abstract

    HE4 Might Participate in Extracellular Matrix Remodeling in Ovarian Cancer via Activation of Fibroblasts

Share Link